Daiichi Sankyo Nordics ApS: Financial statements 2024
CVR: 39371049
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
Daiichi Sankyo Nordics ApS (CVR 39371049) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 57,381,295 and a net result of DKK 8,448,867 compared with DKK 2,350,138 the year before. That is an increase of 20% compared with the year before. Equity in the 2024 report amounted to DKK 14,056,215. The solvency ratio was 7.8%. The company had 26 employees in the financial year.
- Gross Profit
- DKK 57,381,295
- Profit/Loss
- DKK 8,448,867
- Equity
- DKK 14,056,215
- Total Assets
- DKK 181,341,726
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 57.4M | 8.4M | 14.1M | 26 |
| 2023 | - | 47.8M | 2.4M | 5.7M | 24 |
| 2022 | - | 35.6M | 46K | 3.4M | 22 |
| 2021 | - | 27.4M | 846K | 3.3M | 16 |
| 2020 | - | 20.6M | 1.2M | 2.5M | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Daiichi Sankyo Nordics ApS
Daiichi Sankyo Nordics ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Daiichi Sankyo Oncology Nordics ApS. The management consists of Christophe Tiberghien. The board consists of Christophe Tiberghien, Jacob Wessel-Tolvig and Karin Margaretha Heisterberg. The company is owned by Daiichi Sankyo Oncology Europe GmbH. The company has 32 employees (2026). In 2026, the company reported a gross profit of DKK 83,558,930 and a net result of DKK 17,269,490 compared with DKK 9,020,707 the year before. Equity in the 2026 report amounted to DKK 40,346,412.
